Polynucleotides encoding low density lipoprotein receptor
US10323076B2 · kind B2 · utility
45Cited by
401References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 3, 2014 |
| Grant date | Jun 18, 2019 |
| Priority date | — |
| Expiry date | Oct 3, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotide molecules encoding low density lipoprotein receptor comprising at least one mutation (e.g., an LDLR signally enhancing mutation).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.